Scope Infection Lawsuit Patients across the United States have filed medical scope infection lawsuits after contaminated endoscopes and duodenoscopes allegedly transmitted dangerous bacterial infections during procedures such as ERCP, colonoscopy, and other endoscopic treatments.
Spinal Cord Stimulator Lawsuit Spinal cord stimulator lawsuits allege that implanted pain devices malfunctioned, migrated, or caused nerve damage, often forcing patients to undergo revision or removal surgery.
Depo-Provera Lawsuit Depo-Provera lawsuits are being investigated for women who developed meningioma brain tumors after receiving Depo-Provera birth control shots, claiming that Pfizer failed to adequately disclose side effects.
Suboxone Tooth Decay Lawsuit Lawsuits are being pursued by users of Suboxone who experienced tooth loss, broken teeth or required dental extractions. Settlement benefits may be available.
Chlorpyrifos Parkinsonโs Disease Lawsuit Chlorpyrifos lawsuits are being investigated for individuals diagnosed with Parkinsonโs disease after direct, residential, occupational or Gulf War pesticide exposure.
Ozempic Lawsuit Lawyers are pursuing Ozempic lawsuits, Wegovy lawsuits and Mounjaro lawsuits over gastroparesis or stomach paralysis, which can leave users with long-term gastrointestinal side effects
Hair Relaxer Lawsuit Regular exposure to chemicals in hair relaxer may cause uterine cancer, ovarian cancer and other injuries. Women diagnosed with cancer may be eligible for settlement benefits.
Bard PowerPort Lawsuit Serious and life-threatening injuries have been linked to problems with Bard PowerPort. Lawsuits are now being pursued by individuals who suffered injuries from the implantable port catheter fracturing or migrating.
Nitrous Oxide Lawsuit Individuals who suffered harm, or families who lost a loved one after using nitrous oxide products may be eligible for financial compensation through a nitrous oxide lawsuit.
Breast Mesh Lawsuit Lawyers are investigating breast mesh lawsuits for women who suffered infections, pain, or implant failure from internal bra implants used in breast reconstruction surgery.
Schwab YieldPlus Investors Have Another Chance to Opt-Out of Class Action December 10, 2010 Staff Writers Add Your CommentsA $235 million dollar proposed settlement for the Schwab YieldPlus Fund class action lawsuit has been resurrected, after the investment firm backed out of the deal last month. However, investors in the bond fund have been provided an opportunity to opt-out of the settlement and pursue their own Schwab YieldPlus arbitration claim to recover losses.ย Earlier this year, Charles Schwab reached a tentative settlement agreement that would have the company pay investors for some of the losses they suffered after investing in their YieldPlus funds. However, in November, Schwab backed out of the settlement, claiming that they only recently discovered that the agreement would only resolve claims by California investors.Under the new deal, the settlement would cover all investors in the class, unless they choose to opt out and pursue an individual lawsuit or arbitration claim.Do You Know about…Spinal Cord Stimulator lawsuitsSpinal cord stimulator lawsuits are being investigated for individuals who suffered unnecessary shocks, burns or other problems, often resulting in the need for additional surgery to remove the SCS.Learn MoreSEE IF YOU QUALIFY FOR COMPENSATIONDo You Know AboutโฆSpinal Cord Stimulator lawsuitsSpinal cord stimulator lawsuits are being investigated for individuals who suffered unnecessary shocks, burns or other problems, often resulting in the need for additional surgery to remove the SCS.Learn MoreSEE IF YOU QUALIFY FOR COMPENSATIONSchwab YieldPlus funds are ultra-short bond funds, which were heavily promoted as conservative investment alternatives to money market funds or cash. Despite being advertised to generate income with minimal changes in share price, the fund lost more than 30% of its value between June 2007 and June 2008 due to heavy investments in risky subprime mortgage securities, which some experts indicate violated the prospectus.The Schwab class action lawsuit represents about 250,000 investors who say they lost about $800 million when the YieldPlus fund collapsed. The claim alleges that Schwab misled investors and failed to properly disclose the nature of the risks associated with certain securities held by the bond funds. Schwab still faces at least 194 individual stockbroker arbitration claims for up to $34 million. Those investors opted out of the Schwab class action lawsuit prior to the original deadline in December 2009.According to a Supplemental Notice of Proposed Settlement, which was approved on December 1 in the U.S. District Court for the Northern District of California, investors now have a second chance to opt-out of the Schwab YieldPlus settlement. Individual investors have until January 14, 2011 to decide whether they want to participate in the class action settlement or pursue their own individual action.Many financial fraud lawyers have suggested that some investors may be better served by pursuing an individual arbitration claim to recover their Schwab YieldPlus losses through the Financial Industry Regulatory Authority (FINRA), as opposed to participating as a class member. Panels of FINRA arbitrators have already heard a number of claims filed by investors, awarding losses of more than $20 million so far.Three classes of investors have been certified, including individuals and entities who acquired shares of the Schwab YieldPlus Funds Investor Shares (SWYPX) and Schwab YieldPlus Funds Select Shares (SWYSX). The first class includes all individuals or entities who acquired shares between November 15, 2006 and March 17, 2008, who were damaged and received a false and misleading registration statement. The second class includes all individuals or entities who acquired shares between May 31, 2006 and March 17, 2008 who received a false and misleading prospectus for the fund. The final class includes all California investors who held shares on September 1, 2006.In October 2009, Schwab announced that it had received a โWells noticeโ from the U.S. Securities and Exchange Commission (SEC) indicating that they plan to recommend that the company be brought up on civil charges. No charges have yet been filed. Tags: Arbitration, Bond Fund, Broker Arbitration, California, Charles Schwab, Financial Fraud, FINRA, Schwab YieldPlus Image Credit: |More Lawsuit Stories Judge Appoints Spinal Cord Stimulator Lawyers to Leadership Roles in Boston Scientific MDL August 24, 2026 Kratom Addiction Lawsuit Alleges Opioid-Like Products Caused Addiction, Cardiac Injury August 24, 2026 Clear Eyes Recall Issued Due to Risk Eye Drops May Be Contaminated August 24, 2026 0 Comments NameThis field is for validation purposes and should be left unchanged.Share Your CommentsFirst Name*Last NameEmail* Shared Comments*This field is hidden when viewing the formI authorize the above comments be posted on this page Yes NoPost Comment I authorize the above comments be posted on this pageWeekly Digest Opt-In Yes, send me a weekly email with the latest lawsuits, recalls and warnings.Want your comments reviewed by a lawyer?To have an attorney review your comments and contact you about a potential case, provide your contact information below. This will not be published.Contact Phone #Alt Phone #Private CommentsNOTE: Providing information for review by an attorney does not form an attorney-client relationship.CAPTCHAGA SourceGA CampaignGA MediumGA ContentGA TermΔ MORE TOP STORIES Judge Appoints Spinal Cord Stimulator Lawyers to Leadership Roles in Boston Scientific MDL (Posted: today)A federal judge has appointed a group of plaintiffs attorneys to leadership positions in the growing Boston Scientific spinal cord stimulator federal litigation.MORE ABOUT: SPINAL CORD STIMULATOR LAWSUITBoston Scientific Stimulator Lawsuit Alleges Spine Implant Caused Nerve Damage, Shocks (08/18/2026)Nevro Stimulator Lawsuit MDL Request Opposed by Manufacturer (08/14/2026)Abbott Continues to Oppose Spinal Cord Stimulator Lawsuit MDL, Despite Mounting Claims (08/10/2026) Similac Settlement Provides $670M Payout To Resolve 2,000 NEC Lawsuits (Posted: 3 days ago)Abbott Laboratories has agreed to pay $670 million to resolve more than 2,000 Similac NEC injury lawsuits, as the first federal NEC trial against competitor Mead Johnson gets underway.MORE ABOUT: ENFAMIL AND SIMILAC BABY FORMULA LAWSUITMissouri Appeals Court Orders New Trial for Similac, Enfamil NEC Lawsuit (08/20/2026)Enfamil Necrotizing Enterocolitis Lawsuit Set for Trial to Begin This Week (08/11/2026)Neocate Infant Formula Lawsuit Alleges Nutritional Defect Caused Rickets, Bone Fractures (08/05/2026) Dupixent Lymphoma Lawsuit Alleges Atopic Dermatitis Drug Led to Mycosis Fungoides Diagnosis (Posted: 4 days ago)A California woman’s Dupixent lymphoma lawsuit claims the manufacturers knew of the eczema drug’s cancer risks, but refused to inform doctors and patients.MORE ABOUT: DUPIXENT LAWSUITDupixent CTCL Studies Highlighted Cancer Risks For Years, Lawsuit Alleges (08/11/2026)CTCL Lawsuit Alleges Diagnosis Came After Less Than a Year of Dupixent Use (07/29/2026)Lawsuit Alleges Dupixent Caused Mycosis Fungoides Diagnosis (07/21/2026)
Judge Appoints Spinal Cord Stimulator Lawyers to Leadership Roles in Boston Scientific MDL August 24, 2026
Kratom Addiction Lawsuit Alleges Opioid-Like Products Caused Addiction, Cardiac Injury August 24, 2026
Judge Appoints Spinal Cord Stimulator Lawyers to Leadership Roles in Boston Scientific MDL (Posted: today)A federal judge has appointed a group of plaintiffs attorneys to leadership positions in the growing Boston Scientific spinal cord stimulator federal litigation.MORE ABOUT: SPINAL CORD STIMULATOR LAWSUITBoston Scientific Stimulator Lawsuit Alleges Spine Implant Caused Nerve Damage, Shocks (08/18/2026)Nevro Stimulator Lawsuit MDL Request Opposed by Manufacturer (08/14/2026)Abbott Continues to Oppose Spinal Cord Stimulator Lawsuit MDL, Despite Mounting Claims (08/10/2026)
Similac Settlement Provides $670M Payout To Resolve 2,000 NEC Lawsuits (Posted: 3 days ago)Abbott Laboratories has agreed to pay $670 million to resolve more than 2,000 Similac NEC injury lawsuits, as the first federal NEC trial against competitor Mead Johnson gets underway.MORE ABOUT: ENFAMIL AND SIMILAC BABY FORMULA LAWSUITMissouri Appeals Court Orders New Trial for Similac, Enfamil NEC Lawsuit (08/20/2026)Enfamil Necrotizing Enterocolitis Lawsuit Set for Trial to Begin This Week (08/11/2026)Neocate Infant Formula Lawsuit Alleges Nutritional Defect Caused Rickets, Bone Fractures (08/05/2026)
Dupixent Lymphoma Lawsuit Alleges Atopic Dermatitis Drug Led to Mycosis Fungoides Diagnosis (Posted: 4 days ago)A California woman’s Dupixent lymphoma lawsuit claims the manufacturers knew of the eczema drug’s cancer risks, but refused to inform doctors and patients.MORE ABOUT: DUPIXENT LAWSUITDupixent CTCL Studies Highlighted Cancer Risks For Years, Lawsuit Alleges (08/11/2026)CTCL Lawsuit Alleges Diagnosis Came After Less Than a Year of Dupixent Use (07/29/2026)Lawsuit Alleges Dupixent Caused Mycosis Fungoides Diagnosis (07/21/2026)